Clinical Trial Update: Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 study is assessing Zilretta versus Kenalog for knee osteoarthritis in patients with Type 2 diabetes and is currently recruiting. The trial aims to com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Type 2 Diabetes Mellitus

Drugs mentioned

• Kenalog (triamcinolone acetonide)
• ZILRETTA (Triamcinolone acetonide extended-release injectable suspension)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Osteoarthritis, Knee, Diabetes Mellitus, Type 2 | Phase 4 | Status: RECRUITING